Wu Yudong, Li Qian, Zhang Renshuai, Dai Xiaoli, Chen Wujun, Xing Dongming
The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266071, China; Qingdao Cancer Institute, Qingdao University, Qingdao 266071, China.
Qingdao Cancer Institute, Qingdao University, Qingdao 266071, China.
Clin Chim Acta. 2021 May;516:46-54. doi: 10.1016/j.cca.2021.01.008. Epub 2021 Jan 21.
MicroRNAs are a class of endogenous noncoding single-stranded RNA molecules with approximately 20-24 nucleotides and are associated with a broad range of biological processes. Researchers found that microRNAs are abundant in tissues, and more importantly, there are also trace circulating microRNAs that exist in biological fluids. In recent years, circulating microRNAs had emerged as promising diagnostic and prognostic biomarkers for the noninvasive detection of diseases with high specificity and sensitivity. More importantly, specific microRNA expression signatures reflect not only the existence of early-stage diseases but also the dynamic development of advanced-stage diseases, disease prognosis prediction, and drug resistance. To date, an increasing number of potential miRNA biomarkers have been reported, but their practical application prospects are still unclear. Therefore, microRNAs, as potential diagnostic and prognostic biomarkers in a variety of diseases, need to be updated, as they are of great importance in the diagnosis, prognosis and prediction of therapeutic responses. In this review, we summary our current understanding of microRNAs as potential biomarkers in the major diseases (e.g., cancers and cardio-cerebrovascular diseases), which provide the basis for the design of diagnosis and treatment plan and the improvement of the cure rate.
微小RNA是一类内源性非编码单链RNA分子,约有20 - 24个核苷酸,与广泛的生物学过程相关。研究人员发现,微小RNA在组织中含量丰富,更重要的是,生物体液中也存在微量的循环微小RNA。近年来,循环微小RNA已成为有前景的诊断和预后生物标志物,可用于高特异性和高灵敏度的疾病无创检测。更重要的是,特定的微小RNA表达特征不仅反映早期疾病的存在,还反映晚期疾病的动态发展、疾病预后预测和耐药性。迄今为止,已有越来越多潜在的miRNA生物标志物被报道,但其实际应用前景仍不明确。因此,微小RNA作为多种疾病潜在的诊断和预后生物标志物,由于其在疾病诊断、预后及治疗反应预测中具有重要意义,需要不断更新。在本综述中,我们总结了目前对微小RNA作为主要疾病(如癌症和心脑血管疾病)潜在生物标志物的认识,这为诊断和治疗方案的设计以及治愈率的提高提供了依据。